ArticleMolecular cancer therapeutics2022

NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition.

Marta Llaurado Fernandez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.